Prestige Consumer Healthcare Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Prestige Consumer Healthcare Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Mar 31, 2019 | $975.78M | May 13, 2019 |
| FY2015 | Mar 31, 2015 | $713.46M | May 14, 2015 |
| FY2015 | Mar 31, 2014 | $595.64M | May 14, 2015 |
| FY2015 | Mar 31, 2013 | $616.92M | May 14, 2015 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $1.14B | May 9, 2025 |
| FY2025 | Mar 31, 2024 | $1.13B | May 9, 2025 |
| FY2025 | Mar 31, 2023 | $1.13B | May 9, 2025 |
| FY2024 | Mar 31, 2022 | $1.09B | May 15, 2024 |
| FY2023 | Mar 31, 2021 | $943.37M | May 5, 2023 |
| FY2020 | Mar 31, 2020 | $251.24M | May 8, 2020 |
| FY2020 | Dec 31, 2019 | $241.55M | May 8, 2020 |
| FY2020 | Sep 30, 2019 | $238.07M | May 8, 2020 |
| FY2020 | Jun 30, 2019 | $232.15M | May 8, 2020 |
| FY2020 | Mar 31, 2019 | $241.03M | May 8, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Mar 31, 2018 | $255.97M | May 10, 2018 |
| FY2018 | Dec 31, 2017 | $270.62M | May 10, 2018 |
| FY2018 | Sep 30, 2017 | $258.03M | May 10, 2018 |
| FY2018 | Jun 30, 2017 | $256.57M | May 10, 2018 |
| FY2018 | Mar 31, 2017 | $240.67M | May 10, 2018 |
| FY2018 | Dec 31, 2016 | $216.76M | May 10, 2018 |
| FY2018 | Sep 30, 2016 | $215.05M | May 10, 2018 |
| FY2018 | Jun 30, 2016 | $209.58M | May 10, 2018 |
| FY2017 | Mar 31, 2016 | $207.86M | May 17, 2017 |
| FY2017 | Dec 31, 2015 | $200.20M | May 17, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $214.61M | May 9, 2025 |
| FY2025 | Mar 31, 2024 | $209.34M | May 9, 2025 |
| FY2025 | Mar 31, 2023 | ($82.31M) | May 9, 2025 |
| FY2024 | Mar 31, 2022 | $205.38M | May 15, 2024 |
| FY2023 | Mar 31, 2021 | $164.68M | May 5, 2023 |
| FY2020 | Mar 31, 2020 | $37.05M | May 8, 2020 |
| FY2020 | Dec 31, 2019 | $38.06M | May 8, 2020 |
| FY2020 | Sep 30, 2019 | $33.25M | May 8, 2020 |
| FY2020 | Jun 30, 2019 | $33.93M | May 8, 2020 |
| FY2020 | Mar 31, 2019 | ($139.27M) | May 8, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $336.78M | May 9, 2025 |
| FY2025 | Mar 31, 2024 | $342.43M | May 9, 2025 |
| FY2025 | Mar 31, 2023 | ($22.42M) | May 9, 2025 |
| FY2024 | Mar 31, 2022 | $329.92M | May 15, 2024 |
| FY2023 | Mar 31, 2021 | $297.40M | May 5, 2023 |
| FY2020 | Mar 31, 2020 | $73.92M | May 8, 2020 |
| FY2020 | Dec 31, 2019 | $76.40M | May 8, 2020 |
| FY2020 | Sep 30, 2019 | $69.35M | May 8, 2020 |
| FY2020 | Jun 30, 2019 | $71.49M | May 8, 2020 |
| FY2020 | Mar 31, 2019 | ($153.45M) | May 8, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $3.40B | May 9, 2025 |
| FY2025 | Mar 31, 2024 | $3.32B | May 9, 2025 |
| FY2024 | Mar 31, 2023 | $3.35B | May 15, 2024 |
| FY2023 | Mar 31, 2022 | $3.67B | May 5, 2023 |
| FY2022 | Mar 31, 2021 | $3.43B | May 6, 2022 |
| FY2021 | Mar 31, 2020 | $3.51B | May 7, 2021 |
| FY2020 | Mar 31, 2019 | $3.44B | May 8, 2020 |
| FY2019 | Mar 31, 2018 | $3.76B | May 13, 2019 |
| FY2018 | Mar 31, 2017 | $3.91B | May 10, 2018 |
| FY2017 | Mar 31, 2016 | $2.95B | May 17, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $1.57B | May 9, 2025 |
| FY2025 | Mar 31, 2024 | $1.66B | May 9, 2025 |
| FY2024 | Mar 31, 2023 | $1.91B | May 15, 2024 |
| FY2023 | Mar 31, 2022 | $2.09B | May 5, 2023 |
| FY2022 | Mar 31, 2021 | $2.07B | May 6, 2022 |
| FY2021 | Mar 31, 2020 | $2.34B | May 7, 2021 |
| FY2020 | Mar 31, 2019 | $2.35B | May 8, 2020 |
| FY2019 | Mar 31, 2018 | $2.58B | May 13, 2019 |
| FY2018 | Mar 31, 2017 | $3.09B | May 10, 2018 |
| FY2017 | Mar 31, 2016 | $2.20B | May 17, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $1.83B | May 9, 2025 |
| FY2025 | Mar 31, 2024 | $1.66B | May 9, 2025 |
| FY2025 | Mar 31, 2023 | $1.45B | May 9, 2025 |
| FY2025 | Mar 31, 2022 | $1.58B | May 9, 2025 |
| FY2024 | Mar 31, 2021 | $1.36B | May 15, 2024 |
| FY2023 | Mar 31, 2020 | $1.17B | May 5, 2023 |
| FY2022 | Mar 31, 2019 | $1.10B | May 6, 2022 |
| FY2021 | Mar 31, 2018 | $1.18B | May 7, 2021 |
| FY2020 | Mar 31, 2017 | $822.55M | May 8, 2020 |
| FY2019 | Mar 31, 2016 | $744.34M | May 13, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 4 | May 9, 2025 |
| FY2025 | Mar 31, 2024 | 4 | May 9, 2025 |
| FY2025 | Mar 31, 2023 | (1) | May 9, 2025 |
| FY2024 | Mar 31, 2022 | 4 | May 15, 2024 |
| FY2023 | Mar 31, 2021 | 3 | May 5, 2023 |
| FY2020 | Mar 31, 2020 | 0 | May 8, 2020 |
| FY2020 | Dec 31, 2019 | 0 | May 8, 2020 |
| FY2020 | Sep 30, 2019 | 0 | May 8, 2020 |
| FY2020 | Jun 30, 2019 | 0 | May 8, 2020 |
| FY2020 | Mar 31, 2019 | (2) | May 8, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 4 | May 9, 2025 |
| FY2025 | Mar 31, 2024 | 4 | May 9, 2025 |
| FY2025 | Mar 31, 2023 | (1) | May 9, 2025 |
| FY2024 | Mar 31, 2022 | 4 | May 15, 2024 |
| FY2023 | Mar 31, 2021 | 3 | May 5, 2023 |
| FY2020 | Mar 31, 2020 | 0 | May 8, 2020 |
| FY2020 | Dec 31, 2019 | 0 | May 8, 2020 |
| FY2020 | Sep 30, 2019 | 0 | May 8, 2020 |
| FY2020 | Jun 30, 2019 | 0 | May 8, 2020 |
| FY2020 | Mar 31, 2019 | (2) | May 8, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $97.88M | May 9, 2025 |
| FY2025 | Mar 31, 2024 | $46.47M | May 9, 2025 |
| FY2024 | Mar 31, 2023 | $58.49M | May 15, 2024 |
| FY2023 | Mar 31, 2022 | $27.19M | May 5, 2023 |
| FY2022 | Mar 31, 2021 | $32.30M | May 6, 2022 |
| FY2021 | Mar 31, 2020 | $94.76M | May 7, 2021 |
| FY2020 | Mar 31, 2019 | $27.53M | May 8, 2020 |
| FY2019 | Mar 31, 2018 | $32.55M | May 13, 2019 |
| FY2018 | Mar 31, 2017 | $41.86M | May 10, 2018 |
| FY2018 | Mar 31, 2016 | $27.23M | May 10, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $992.36M | May 9, 2025 |
| FY2025 | Mar 31, 2024 | $1.13B | May 9, 2025 |
| FY2024 | Mar 31, 2023 | $1.35B | May 15, 2024 |
| FY2023 | Mar 31, 2022 | $1.48B | May 5, 2023 |
| FY2022 | Mar 31, 2021 | $1.48B | May 6, 2022 |
| FY2021 | Mar 31, 2020 | $1.73B | May 7, 2021 |
| FY2020 | Mar 31, 2019 | $1.80B | May 8, 2020 |